↓ Skip to main content

Dove Medical Press

Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches

Overview of attention for article published in International Journal of Nanomedicine, August 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
135 Mendeley
Title
Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
Published in
International Journal of Nanomedicine, August 2015
DOI 10.2147/ijn.s82310
Pubmed ID
Authors

Carolina Velasco-Aguirre, Francisco Morales, Eduardo Gallardo-Toledo, Simon Guerrero, Ernest Giralt, Eyleen Araya, Marcelo J Kogan

Abstract

An exciting and emerging field in nanomedicine involves the use of gold nanoparticles (AuNPs) in the preclinical development of new strategies for the treatment and diagnosis of brain-related diseases such as neurodegeneration and cerebral tumors. The treatment of many brain-related disorders with AuNPs, which possess useful physical properties, is limited by the blood-brain barrier (BBB). The BBB highly regulates the substances that can permeate into the brain. Peptides and proteins may represent promising tools to improve the delivery of AuNPs to the central nervous system (CNS). In this review, we summarize the potential applications of AuNPs to CNS disorders, discuss different strategies based on the use of peptides or proteins to improve the delivery of AuNPs to the brain, and examine the intranasal administration route, which bypasses the BBB. We also analyze the potential neurotoxicity of AuNPs and the perspectives and new challenges concerning the use of peptides and proteins to enhance the delivery of AuNPs to the brain. The majority of the work described in this review is in a preclinical stage of experimentation, or in select cases, in clinical trials in humans. We note that the use of AuNPs still requires substantial study before being translated into human applications. However, for further clinical research, the issues related to the potential use of AuNPs must be analyzed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Italy 1 <1%
Unknown 133 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 29 21%
Student > Bachelor 21 16%
Student > Master 21 16%
Researcher 18 13%
Student > Doctoral Student 7 5%
Other 14 10%
Unknown 25 19%
Readers by discipline Count As %
Agricultural and Biological Sciences 24 18%
Chemistry 21 16%
Biochemistry, Genetics and Molecular Biology 15 11%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Medicine and Dentistry 10 7%
Other 28 21%
Unknown 27 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2015.
All research outputs
#14,600,553
of 25,374,917 outputs
Outputs from International Journal of Nanomedicine
#1,525
of 4,123 outputs
Outputs of similar age
#126,556
of 276,431 outputs
Outputs of similar age from International Journal of Nanomedicine
#35
of 141 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,123 research outputs from this source. They receive a mean Attention Score of 4.7. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,431 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.